more-arw search

What does Paul Herron think?

Seasoned CFO and Business Development VP in the biopharmaceutical industry EducationMBA, Management : Fuqua School of Business (at Duke University ) - [1974 to 1976]  See full profile

I like the analogy of an infant becoming a toddler, child, adolescent, and adult. You start with a newborn invention or idea and a founder's vision...
The "going concern" issue really becomes sticky for early-stage companies, particularly in industries like biotechnology where progress can be...
I agree. When the CEO needs help in formulating and executing strategy, deploying capital effectively, and in seeing the bigger, longer-term picture...